Medscape |
Cardiac Risk the Same With All Sulfonylureas in Diabetes
Medscape The cardiovascular risk profile associated with the use of sulfonylureas in type 2 diabetes does not differ significantly between specific, short-acting agents and their nonspecific, long-acting counterparts, a large new cohort study suggests. However ... |
from diabetes - Google News
![[OC] Build Your Own Dexcom App update- bugfixes and base version updates](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
Social Plugin